Publications by authors named "Ingvild Farnes"

Claim this Profile
A
Association between baseline quality of life and survival in patients with non-metastatic, advanced pancreatic cancer.
Gyda G Christiansen, Ingvild Farnes, Marianne J Hjermstad, Knut Jørgen Labori

Scand J Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Ingvild Farnes, Caroline S Verbeke, Dyre Kleive, Anne Waage, Tore Tholfsen

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial.
Jacob Ghotbi, Ingvild Farnes, Dyre Kleive, Caroline Verbeke, Aart Issa Epe

Ann Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: From BRPC to LAPC-Rethinking Resectability in Pancreatic Cancer.
Jacob Ghotbi, Ingvild Farnes, Knut Jørgen Labori

Ann Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer.
Peder R Braadland, Ingvild Farnes, Elin H Kure, Sheraz Yaqub, Adrian McCann

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study.
Ingvild Farnes, Marius Lund-Iversen, Lars Aabakken, Caroline Verbeke, Knut Jørgen Labori

Scand J Gastroenterol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study.
Ingvild Farnes, Vemund Paulsen, Caroline Sofie Verbeke, Christer Julseth Tønnesen, Lars Aabakken

Scand J Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).
Ingvild Farnes, Dyre Kleive, Caroline S Verbeke, Lars Aabakken, Aart Issa-Epe

BJS Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft type for superior mesenteric and portal vein reconstruction in pancreatic surgery - A systematic review.
Knut J Labori, Dyre Kleive, Ammar Khan, Ingvild Farnes, Bjarte Fosby

HPB (Oxford)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of gastric conduit retention following hybrid and minimally invasive esophagectomy for esophageal cancer: Two retrospective case series.
Ingvild Farnes, Egil Johnson, Hans-Olaf Johannessen

Int J Surg Case Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis